(Q84306347)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19638271%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

title

Inactivated Polio Vaccine (IPV): a strong candidate vaccine for achieving global polio eradication program (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19638271%20AND%20SRC:MED&resulttype=core&format=json

eradication of infectious diseases

3 February 2020

main subject

1 reference

1 reference

2

Gottfried Köhler

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19638271%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

author name string

Aamir Shahzad

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19638271%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

publication date

26 July 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19638271%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19638271%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

volume

27

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19638271%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

issue

39

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19638271%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

page(s)

5293-5294

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19638271%20AND%20SRC:MED&resulttype=core&format=json

VACCINE-DERIVED POLIOVIRUSES AND THE ENDGAME STRATEGY FOR GLOBAL POLIO ERADICATION *

3 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.06.106

Comparative evaluation of immunization with live attenuated and enhanced-potency inactivated trivalent poliovirus vaccines in childhood: systemic and local immune responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.06.106

Role of injectable and oral polio vaccines in polio eradication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.06.106

Poliomyelitis Prevention: Recommendations for Use of Inactivated Poliovirus Vaccine and Live Oral Poliovirus Vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.06.106

Economics of polio vaccination in the post-eradication era: should OPV-using countries adopt IPV?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.06.106

Technologies that make administration of vaccines safer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.06.106

Antibody response to poliomyelitis vaccine administered by jet injection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.06.106

10.1016/J.VACCINE.2009.06.106

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19638271%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

1 reference